Screener
Merck & Co. MRK Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Merck & Co. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The source filing: Merck & Co.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:11 PM EDT
- Fiscal quarter
- Q3 FY2028
- Calendar quarter
- Q3 2028
- Accession
- 0000310158-26-000212
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Current Liabilities | ||
| Loans payable and current portion of long-term debt | $2,825 | $2,589 |
| Trade accounts payable | 3,827 | 4,404 |
| Accrued and other current liabilities | 14,725 | 14,468 |
| Income taxes payable | 4,224 | 4,726 |
| Dividends payable | 2,130 | 2,140 |
| Total current liabilities | 27,731 | 28,327 |
| Long-Term Debt | 51,081 | 46,750 |
Item 1. Financial Statements
FAQ
- What is Merck & Co.'s accrued expenses?
- Merck & Co. (MRK) reported accrued expenses of $14.73B in Q2 2026.
- How has Merck & Co.'s accrued expenses changed year-over-year?
- Merck & Co.'s accrued expenses increased by 1.5% year-over-year, from $14.5B to $14.73B.
- What is the long-term trend for Merck & Co.'s accrued expenses?
- Over 5 years (2020 to 2025), Merck & Co.'s accrued expenses has grown at a 220.2% compound annual growth rate (CAGR), from $43M to $14.47B.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Merck & Co.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude